PharVision Advisers’s AvidXchange AVDX Stock Holding History

PharVision Advisers’s Portfolio AVDX Stock Details AVDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,200	Closed	-$230K	–	285
2024 Q4	$230K	Buy	+22,200	New	+$217K	0.19%	246

Other funds holding AVDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

NRCM

North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCVI

Bain Capital Venture Investors Boston, Massachusetts $175M AUM 21.91% 1-Year Est. Return

PharVision Advisers's AVDX Position: Q1 2025 in Review

PharVision Advisers sold out of AvidXchange (AVDX) in Q1 2025, closing a stake of 22,200 shares — an estimated $230K sold.

PharVision Advisers first reported a position in AVDX in Q4 2024 and held it in 1 quarter. The position peaked at $230K in Q4 2024. 209 funds tracked by Wall St. Rank hold AVDX as of Q1 2025.

PharVision Advisers reported no remaining AvidXchange position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 22,200 AvidXchange shares in Q1 2025, an estimated $230K.
PharVision Advisers first reported a position in AvidXchange in Q4 2024 and held it in 1 quarter.
PharVision Advisers's AvidXchange position peaked at $230K in Q4 2024.
209 funds tracked by Wall St. Rank held AvidXchange as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.